Acute and subchronic effects of amitriptyline on processing capacity in neuropathic pain patients using visual event-related potentials: Preliminary findings

Psychopharmacology

Volumn 183, Issue 4, 2006, Pages 462-470

  Veldhuijzen, D S ^a,b   Kenemans, J L ^a,c   Van Wijck, A J M ^b   Olivier, B ^a   Kalkman, C J ^b   Volkerts, E R ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Amitriptyline; Attention; ERPs; Neuropathic pain; Processing capacity

Indexed keywords

AMITRIPTYLINE; PLACEBO;

ADULT; AMPLITUDE MODULATION; ARTICLE; ATTENTION; BRAIN FUNCTION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EFFECT; ELECTRODE; EVOKED VISUAL RESPONSE; FEMALE; HUMAN; MALE; NEUROPATHIC PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STIMULUS RESPONSE; TASK PERFORMANCE; TIME SERIES ANALYSIS; VISION;

ADULT; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS; ATTENTION; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS, VISUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; REACTION TIME;

EID: 28344449009     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0204-3     Document Type: Article

References (26)

1. Amado-Boccara I, Gougoulis N, Poirier Littré MF, Galinowski A, Lôo H (1995) Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev 19:479-493
2. Beekman AT, Deeg DJ, Van Limbeck J, Braam AW, De Vries MZ, Van Tilburg W (1997) Criterion validity of the Center for Epidemiologic Studies Depression scale (CES-D): results from a community-based sample of older subjects in the Netherlands. Psychol Med 27:231-235
3. Bledowski C, Prvulovic D, Hoechstetter K, Scherg M, Wibral M, Goebel R, Linden DE (2004) Localizing P300 generators in visual target and distractor processing: a combined event-related potential and functional magnetic resonance imaging study. J Neurosci 24:9353-9360
4. Deptula D, Pomara N (1990) Effects of antidepressants on human performance: a review. J Clin Psychopharmacol 10:105-111
5. Dick BD, Connolly JF, McGrath PJ, Finley GA, Stroink G, Houlihan ME, Clark AJ (2003) The disruptive effect of chronic pain on mismatch negativity. Clin Neurophysiol 114:1497-1506
6. Eccleston C (1994) Chronic pain and attention: a cognitive approach. Br J Clin Psychol 33:535-547
7. Gratton G, Coles MG, Donchin E (1983) A new method for off-line removal of ocular artifact. Electroencephalogr Clin Neurophysiol 55:468-484
8. Hoeksma MR, Kemner C, Verbaten MN, van Engeland H (2004) Processing capacity in children and adolescents with pervasive developmental disorders. J Autism Dev Disord 34:341-354
9. Houlihan ME, McGrath PJ, Connelly JF, Stroink G, Finley GA, Dick B, Phi T (2004) Assessing the effect of pain on demands for attentional resources using ERP's. Int J Psychophysiol 51:181-187
10. Jonkman LM, Kemner C, Verbaten MN, Van Engeland H, Camfferman G, Buitelaar JK, Koelega HS (2000) Attentional capacity, a probe ERP study: differences between children with attention-deficit hyperactivity disorder and normal control children and effects of methylphenidate. Psychophysiology 37:334-346
11. Kenemans JL, Verbaten MN, Melis CJ, Slangen JL (1992) Visual stimulus change and the orienting reaction: event-related potential evidence for a two-stage process. Biol Psychol 33:97-114
12. Knegtering H, Eijck M, Huijsman A (1994) Effects of antidepressants on cognitive functioning of elderly patients. Drugs Aging 5:192-199
13. Kok A (2001) On the utility of P3 amplitude as a measure of processing capacity. Psychophysiology 38:557-577
14. Kramer AF, Trejo LJ, Humphrey D (1995) Assessment of mental workload with task-irrelevant auditory probes. Biol Psychol 40:83-100
15. McCleane G (2003) Pharmacological management of neuropathic pain. CNS Drugs 17:1031-1043
16. McNair DM, Lorr M, Droppleman LF (1971) Edits manual for the Profile of Mood States. Educational and Industrial Testing Service, San Diego
17. McQuay HJ, Tramer M, Nye BA, Carroll D, Wiffen PJ, Moore RA (1996) A systematic review of antidepressants in neuropathic pain. Pain 68:217-227
18. Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277-299
19. Polich J, Kok A (1995) Cognitive and biological determinants of P300: an integrative review. Biol Psychol 41:103-146
20. Robbe HMJ, O'Hanlon JF (1995) Acute and subchronic effects of paroxetine 20 and 40 mg on actual driving, psychomotor performance and subjective assessments in healthy volunteers. Eur Neuropsychopharmacol 5:35-42
21. Spielberger CD (1983) Manual for the State-Trait Anxiety Inventory (STAI-form Y). Consulting Psychologists, Palo Alto
22. Thompson PJ (1991) Antidepressants and memory: a review. Hum Psychopharmacol 6:79-90
23. Van Laar MW, Volkerts ER, Verbaten MN, Trooster S, van Megen HJ, Kenemans JL (2002) Differential effects of amitriptyline, nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory. Psychopharmacology (Berl) 162:351-363
24. Verbaten MN, Huyben MA, Kemner C (1997) Processing capacity and the frontal P3. Int J Psychophysiol 25:237-248
25. Volz H, Sturm Y (1995) Antidepressant drugs and psychomotor performance. Neuropsychobiology 31:146-155
26. Wickens C, Kramer A, Vanasse L, Donchin E (1983) Performance of concurrent tasks: a psychophysiological analysis of the reciprocity of information-processing resources. Science 221: 1080-1082